V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20158004 | 20060429 | 1.58 | 43 | Neo-adjuvant (N) | 2018-01-09 | 2018-01-16 | ECX | N | N | ECX | 101303035 |
| 20158007 | 20060430 | null | 77.6 | Neo-adjuvant (N) | 2019-07-21 | 2019-07-28 | ECX | 02 | N | ECX | 101595452 |
| 20158008 | 20060431 | 1.72 | 82.4 | Neo-adjuvant (N) | 2018-04-16 | 2018-04-23 | ECX | N | N | ECX | 100649992 |
| 20158010 | 20060432 | 1.5 | 82.6 | Palliative (P) | 2017-01-28 | 2017-03-03 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101493594 |
| 20158011 | 20060433 | 1.52 | 46.2 | Neo-adjuvant (N) | 2018-03-19 | 2018-04-02 | ECX | N | N | ECX | 100939659 |
| 20158012 | 20060434 | 1.69 | 87.4 | Palliative (P) | 2019-02-05 | 2019-02-06 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101287051 |
| 20158013 | 20060435 | 1.5 | 72 | Palliative (P) | 2017-07-11 | 2017-07-21 | ECX | N | N | ECX | 100750139 |
| 20158014 | 20060436 | 1.82 | 69.8 | Adjuvant (A) | 2017-06-30 | 2017-07-08 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101239166 |
| 20158016 | 20060437 | 1.58 | 112.3 | Curative (C) | 2016-07-15 | 2016-07-25 | ECX | N | N | ECX | 101192695 |
| 20158019 | 20060438 | 1.8 | 67.4 | Adjuvant (A) | 2017-12-22 | 2018-01-05 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100488717 |
| 20158020 | 20060439 | 1.69 | 66.4 | Palliative (P) | 2017-01-10 | 2017-01-16 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100647823 |
| 20158021 | 20060440 | 1.8 | 103 | Neo-adjuvant (N) | 2017-08-21 | 2017-08-27 | ECX | 02 | N | ECX | 101428606 |
| 20158022 | 20060441 | 1.82 | 91 | Palliative (P) | null | 2020-03-05 | Gemcitabine + Capecitabine | N | null | CAPECITABINE + GEMCITABINE | 100046790 |
| 20158023 | 20060442 | 1.6 | 55.8 | Palliative (P) | 2016-12-07 | 2016-12-28 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101480997 |
| 20158026 | 20060443 | 1.56 | 54 | Curative (C) | 2017-07-17 | 2017-07-31 | ECX | N | N | ECX | 101728188 |
| 20158027 | 20060444 | 1.74 | 91.8 | Palliative (P) | 2018-01-07 | 2018-01-23 | Gemcitabine + Capecitabine | N | N | CAPECITABINE + GEMCITABINE | 100646798 |
| 20158028 | 20060445 | 1.55 | 73 | null | null | 2019-03-28 | ECX | null | null | ECX | 101719779 |
| 20158030 | 20060446 | 1.7 | 69 | Palliative (P) | 2016-08-21 | 2016-09-09 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100401627 |
| 20158031 | 20060447 | 1.49 | null | Palliative (P) | 2019-12-19 | 2019-12-19 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100762866 |
| 20158032 | 20060448 | 1.65 | 75.6 | Palliative (P) | 2020-01-10 | 2020-01-15 | ECX | N | N | CAPECITABINE + GEMCITABINE | 101007707 |
| 20158033 | 20060449 | null | null | Palliative (P) | 2019-07-03 | 2019-07-13 | ECX | N | N | ECX | 100840565 |
| 20158034 | 20060450 | 1.57 | 74 | Adjuvant (A) | 2017-08-18 | 2017-09-13 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100082448 |
| 20158035 | 20060451 | 1.8 | 67 | Neo-adjuvant (N) | 2018-12-31 | 2019-01-04 | ECX | N | N | ECX | 101128250 |
| 20158037 | 20060452 | 1.64 | 56.5 | Neo-adjuvant (N) | 2016-10-06 | 2016-10-07 | ECX | 2 | N | ECX | 100461514 |
| 20158039 | 20060453 | null | null | Neo-adjuvant (N) | 2019-05-27 | 2019-06-04 | ECX | N | N | ECX | 100750858 |
| 20158042 | 20060454 | 1.61 | 60.25 | Adjuvant (A) | 2017-06-11 | 2017-06-12 | Gemcitabine + Capecitabine | N | N | CAPECITABINE + GEMCITABINE | 101498672 |
| 20158044 | 20060455 | 1.76 | 74.6 | Adjuvant (A) | 2020-05-18 | 2020-05-31 | Gemcitabine + Capecitabine | 2 | N | CAPECITABINE + GEMCITABINE | 100950802 |
| 20158045 | 20060456 | 1.61 | 69 | Neo-adjuvant (N) | 2017-01-28 | 2017-02-11 | ECX | N | null | ECX | 101110809 |
| 20158046 | 20060457 | 1.55 | 67.15 | Palliative (P) | 2016-06-09 | 2016-06-27 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100737045 |
| 20158048 | 20060458 | 1.59 | 68.4 | Adjuvant (A) | null | 2016-06-26 | Gemcitabine + Capecitabine | 01 | N | CAPECITABINE + GEMCITABINE | 101559684 |
| 20158049 | 20060459 | null | null | Adjuvant (A) | 2017-05-18 | 2017-05-18 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100655727 |
| 20158051 | 20060460 | 1.53 | 75.5 | Palliative (P) | 2018-05-27 | 2018-05-27 | ECX | 02 | N | ECX | 100215198 |
| 20158052 | 20060461 | 1.6 | 75.3 | Neo-adjuvant (N) | 2019-08-12 | 2019-08-18 | ECX | 2 | N | ECX | 100594540 |
| 20158053 | 20060462 | 1.69 | 74.05 | Curative (C) | 2020-02-28 | 2020-02-28 | ECX | 2 | N | ECX | 100537388 |
| 20158057 | 20060463 | 1.56 | 68.55 | Adjuvant (A) | 2019-04-04 | 2019-04-18 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 100935666 |
| 20158059 | 20060464 | 1.43 | 73 | Adjuvant (A) | 2017-01-17 | 2017-01-28 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100638401 |
| 20158061 | 20060465 | 1.79 | 66.9 | Palliative (P) | 2018-04-11 | 2018-04-21 | ECX | 02 | N | ECX | 100044520 |
| 20158064 | 20060466 | 1.6 | 75 | Neo-adjuvant (N) | 2019-09-09 | 2019-09-17 | ECX | N | N | ECX | 100263342 |
| 20158065 | 20060467 | 1.77 | 68.9 | Adjuvant (A) | 2017-12-25 | 2018-01-13 | Gemcitabine + Capecitabine | N | N | CAPECITABINE + GEMCITABINE | 100839297 |
| 20158067 | 20060468 | 1.6 | 65 | Adjuvant (A) | 2019-01-04 | 2019-01-17 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100523072 |
| 20158068 | 20060469 | 1.75 | 120.1 | Curative (C) | 2017-12-23 | 2017-12-29 | ECX | N | N | ECX | 100610602 |
| 20158069 | 20060470 | 1.77 | 94.8 | Adjuvant (A) | 2016-04-04 | 2016-04-16 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101336414 |
| 20158070 | 20060471 | 1.67 | 84 | Adjuvant (A) | 2018-03-16 | 2018-03-30 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100731347 |
| 20158071 | 20060472 | 1.63 | 101 | Neo-adjuvant (N) | 2018-04-18 | 2018-04-18 | ECX | 02 | N | ECX | 100138501 |
| 20158072 | 20060473 | 1.64 | 74.8 | Neo-adjuvant (N) | 2017-10-07 | 2017-10-19 | ECX | N | N | ECX | 101280435 |
| 20158073 | 20060474 | 1.76 | 85 | Adjuvant (A) | 2020-10-20 | 2020-10-26 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100437182 |
| 20158074 | 20060475 | 1.85 | 108 | Palliative (P) | 2018-11-06 | 2018-11-11 | ECX | N | N | ECX | 101299310 |
| 20158076 | 20060476 | 1.73 | 78.8 | Palliative (P) | 2016-04-02 | 2016-04-07 | Gemcitabine + Capecitabine | N | N | CAPECITABINE + GEMCITABINE | 101862123 |
| 20158083 | 20060477 | 1.72 | 72 | Neo-adjuvant (N) | 2016-11-06 | 2016-11-07 | ECX | N | N | ECX | 100793230 |
| 20158084 | 20060478 | 1.66 | 87 | Adjuvant (A) | 2016-08-16 | 2016-08-26 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100665631 |